USPTO serial 86361387
Reviewed by CopyMark Law Group
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ian W. Gillies
IAN W. GILLIES Knobbe Martens Olson & Bear Llp2040 Main St Fl 14Irvine, CA 92614-8214UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for use in preparing molecules for genomic research and analysis; a kit for extracting and labeling biopolymers for research purposes, containing enzymes, color reagents, buffers, and other reagents; Polynucleotide isolation and purification kit consisting of enzymes, color reagents, buffers, and other reagents used for scientific or medical research purposes; kits for extracting and labeling polynucleotide molecules for research purposes, containing enzymes, color reagents, buffers, and other reagents; reagents for use in preparing polynucleotide molecules for genomic research; diagnostic kits containing enzymes, color reagents, buffers, and other reagents for extracting and labeling polynucleotide molecules | SECTION 8 - CANCELLED | May 13, 2013 |
| 005 | Reagents for use in clinical medicine for preparing molecules for genomic analysis; a medical diagnostic kit containing enzymes, color reagents, buffers, and other reagents for extracting and labeling biopolymers | SECTION 8 - CANCELLED | May 13, 2013 |
| 009 | An imaging system, namely, an imaging apparatus and software, for the analysis of biopolymer samples in scientific or medical research; software used in the analysis of biopolymer samples for medical diagnostic purposes; software used in the analysis of biopolymer samples for scientific or medical research; an imaging apparatus for use in the analysis of biopolymer samples in scientific or medical research; Nanofluidic devices, namely, solid state substrates in the nature of plates, chips and wafers, and software, both of the foregoing for genomic imaging and analysis;An imaging apparatus and software for genomic analysis in scientific or medical research; an imaging system, namely, an imaging apparatus and software sold as a unit, for genomic analysis in scientific or medical research; software for genomic analysis used for medical diagnostic purposes; Genomic data analysis software; software for interpreting and analyzing data generated by an imaging apparatus for the purpose of studying biopolymer samples; Solid state substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels for confining and linearizing biopolymer samples; disposable substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels to facilitate genomic imaging and analysis; Solid state substrates, namely, plates, chips and wafers having a plurality of fluid passageways for confining and linearizing macromolecules including biopolymer molecules for scientific or medical research; nanochannel wafers, for scientific or medical research, used in instruments for genomic analysis | SECTION 8 - CANCELLED | Sep 30, 2012 |
| 010 | A medical diagnostic imaging system, namely, an imaging apparatus and software sold as a unit and used in the analysis of biopolymer samples; a medical diagnostic imaging apparatus used in the analysis of biopolymer samples; A medical diagnostic imaging system, namely, an imaging apparatus and software sold as a unit for genomic analysis; a medical imaging apparatus for genomic analysis; Solid state substrates, namely, plates, chips, and wafers for use in clinical medicine, having a pattern of channels for confining and linearizing biopolymer samples; disposable substrates, namely, plates, chips, and wafers for use in clinical medicine, having a pattern of channels to facilitate genomic imaging and analysis; Medical diagnostic solid state substrates, namely, plates, chips and wafers for confining and linearizing macromolecules including biopolymer molecules; nanochannel wafers, for use in clinical medicine, used in instruments for genomic analysis | SECTION 8 - CANCELLED | Sep 30, 2012 |
| 042 | Product research and development and consulting services for others in the fields of biopolymer imaging and analysis; genomic mapping, genomic imaging, and genomic analysis services for scientific research purposes | SECTION 8 - CANCELLED | Jun 13, 2012 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2023 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Nov 8, 2021 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 21, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 21, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 19, 2018 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Nov 8, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 23, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 23, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 3, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 20, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 13, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 22, 2016 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 19, 2015 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jun 19, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 19, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 19, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 19, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 10, 2015 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 9, 2015 | ISER | WITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST | — |
| Apr 7, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 7, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 18, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 3, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 3, 2015 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 12, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 11, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 11, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 29, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 23, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 20, 2014 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 19, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 12, 2014 | NWAP | NEW APPLICATION ENTERED | — |